Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

CEPHEUS Trial: Updates in Front-line Treatment for Ineligible Myeloma

Key Insights from CARTITUDE-4 Study Presented at ASH 2024

Understanding the CAR-T Therapy Process for Treating Multiple Myeloma Patients

Key Takeaways from the CARTITUDE-4 Study at ASH 2024

Front-Line Treatment Goals for Transplant-Ineligible Newly Diagnosed Multiple Myeloma

CAR-T Therapy: Bridging Strategies for Multiple Myeloma Treatment Advancement

ASH 2024: IVIG Use With Bispecific Antibodies

Systematic Review and Meta-Analysis Findings Presented at ASH 2024

Guideline-Based Treatment Options for Transplant-Ineligible or Deferred NDMM
‍
‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.